These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 214657)

  • 1. Reduced PGE1 stimulated 3H-cAMP accumulation in platelets from schizophrenics.
    Rotrosen J; Miller AD; Mandio D; Traficante LJ; Gershon S
    Life Sci; 1978 Nov; 23(20):1989-96. PubMed ID: 214657
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostaglandins, platelets, and schizophrenia.
    Rotrosen J; Miller AD; Mandio D; Traficante LJ; Gershon S
    Arch Gen Psychiatry; 1980 Sep; 37(9):1047-54. PubMed ID: 6251771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced cyclic AMP production in the blood platelets from schizophrenic patients.
    Kafka MS; van Kammen DP; Bunney WE
    Am J Psychiatry; 1979 May; 136(5):685-7. PubMed ID: 219720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenia and reduced cyclic AMP production: evidence for the role of receptor-linked events.
    Garver DL; Johnson C; Kanter DR
    Life Sci; 1982 Nov; 31(18):1987-92. PubMed ID: 6294425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV; Gorman RR
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin receptor sensitivity in psychiatric disorders.
    Kanof PD; Johns C; Davidson M; Siever LJ; Coccaro EF; Davis KL
    Arch Gen Psychiatry; 1986 Oct; 43(10):987-93. PubMed ID: 3019269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acute methadone withdrawal on prostaglandin E-stimulated 3H-cyclic adenosine monophosphate accumulation in human platelets.
    Pandey GN; DeLeon-Jones FA; Inwang EE; Davis JM
    Clin Pharmacol Ther; 1980 May; 27(5):607-11. PubMed ID: 6245830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet prostaglandin E1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and in inhibitory effects on aggregation.
    Kaiya H; Ofuji M; Nozaki M; Tsurumi K
    Psychopharmacol Bull; 1990; 26(3):381-4. PubMed ID: 2177206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alpha 2-adrenergic system of the platelet in cystic fibrosis.
    Davis PB; Dieckman L; Boat TF; Stern RC; Doershuk CF
    Am J Med Sci; 1984 Oct; 288(3):104-8. PubMed ID: 6091455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ADP on PGE1 formation in blood platelets from patients with depression, mania and schizophrenia.
    Abdulla YH; Hamadah K
    Br J Psychiatry; 1975 Dec; 127():591-5. PubMed ID: 1201454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets.
    Tateson JE; Moncada S; Vane JR
    Prostaglandins; 1977 Mar; 13(3):389-97. PubMed ID: 191877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic AMP response to prostaglandin E1 in mononuclear cells from peripheral blood and synovial fluid of patients with rheumatoid arthritis.
    Zurier RB; Doty J; Goldenberg A
    Prostaglandins; 1977 Jan; 13(1):25-31. PubMed ID: 190647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin).
    Feinstein MB; Egan JJ; Sha'afi RI; White J
    Biochem Biophys Res Commun; 1983 Jun; 113(2):598-604. PubMed ID: 6307295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA; Murphy W; Haslam RJ
    Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotides in hypertension.
    Hamet P; Franks DJ; Adnot S; Coquil JF
    Adv Cyclic Nucleotide Res; 1980; 12():11-23. PubMed ID: 6250345
    [No Abstract]   [Full Text] [Related]  

  • 18. Do human platelets have opiate receptors?
    Reches A; Eldor A; Vogel Z; Salomon Y
    Nature; 1980 Nov; 288(5789):382-3. PubMed ID: 6253832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC; Guccione MA; Packham MA; Mustard JF
    Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of blood platelet function by cyclic nucleotides.
    Haslam RJ; Davidson MM; Davies T; Lynham JA; McClenaghan MD
    Adv Cyclic Nucleotide Res; 1978; 9():533-52. PubMed ID: 208396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.